Cempra To Combine With Melinta, To Add The Safest And Most Effective Fluoroquinolone Ever Developed [Seeking Alpha]
CEMPRA (CEMP)
US:NASDAQ Investor Relations:
ir.melinta.com/investor-relations
Company Research
Source: Seeking Alpha
Summary News Coverage Based on some readings of the Cempra merger situation , we see a clear and strong story about two loser companies, Cempra (NASDAQ: CEMP ) and Melinta, that have wasted shareholder capital and are intent on doing more of this together. Is this the case? Let's examine the evidence. It's Not Just 9,000 vs. 6,000 From this SEC filing , we can see that the transcript of the August 9 conference call. Here is a quote from Cempra's CEO, Dr. David Zaccardelli: The FDA Advisory Committee briefing document described pre-approval safety data from a possible 12,000 additional solithromycin patients, and the CRL recommended pre-approval data from additional 9,000 solithromycin patients. The FDA also communicated to us their perspective that approximately 75% of the solithromycin patients in the additional safety study should be on IV solithromycin. We met with the FDA this past February to discuss the complete response letter and how we co
Show less
Read more
Impact Snapshot
Event Time:
CEMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CEMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CEMP alerts
High impacting CEMPRA news events
Weekly update
A roundup of the hottest topics